SLUS:XETRA:XETRA-iShares MSCI USA ESG Screened UCITS ETF USD (Dist) (EUR)

ETF | Others |

Last Closing

USD 10.932

Change

-0.11 (-1.03)%

Market Cap

USD 0.32B

Volume

0.14M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.01 (-0.03%)

USD 446.30B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.01 (+0.06%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.02 (+0.05%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.11 (-0.38%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.06 (+0.22%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.03 (+0.07%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

+0.32 (+0.22%)

USD 102.09B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.05 (-0.10%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.76 (-0.71%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-6.12 (-1.00%)

USD 80.38B

ETFs Containing SLUS:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.28% 60% D- 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.28% 60% D- 57% F
Trailing 12 Months  
Capital Gain 33.99% 90% A- 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 33.99% 89% A- 88% B+
Trailing 5 Years  
Capital Gain 103.58% 96% N/A 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 103.58% 96% N/A 92% A
Average Annual (5 Year Horizon)  
Capital Gain 17.21% 88% B+ 85% B
Dividend Return 17.21% 88% B+ 84% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 16.40% 29% F 41% F
Risk Adjusted Return 104.97% 92% A 93% A
Market Capitalization 0.32B 55% F 49% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.